Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

1589 results found

2024 ∙ Tinessia, A. Clark, K. Randell, M. Leask, J. King, C.

Strategies to address COVID-19 vaccine hesitancy in First Nations peoples: a systematic review

  • All age groups
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Riemma, G. Etrusco, A. Laganà, A. S. Torella, M. Vastarella, M. G. Della Corte, L. D'Amato, A. La Verde, M. De Franciscis, P. Cobellis, L.

Susceptibility to Infection and Impact of COVID-19 Vaccines on Symptoms of Women with Endometriosis: A Systematic Review and Meta-Analysis of Available Evidence

  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Wong, B. K. Mabbott, N. A.

Systematic review and meta-analysis of COVID-19 mRNA vaccine effectiveness against hospitalizations in adults

  • Adults
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Moradiya, P. Khandelwal, P. Raina, R. Mahajan, R. G.

Systematic Review of Individual Patient Data COVID-19 Infection and Vaccination-Associated Thrombotic Microangiopathy

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Sahli, S. Stordal, K.

Systematic review of socioeconomic factors and COVID-19 in children and adolescents

  • Children
  • COVID-19
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Cahuapaza-Gutierrez, N. L.

Systemic lupus erythematosus following COVID-19 vaccination. A systematic review of case reports and case series

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Li, C. Li, P. Peddibhotla, B. Teng, C. Shi, A. Lu, X. Cai, P. Dai, Q. Wang, B.

Takotsubo syndrome and vaccines: a systematic review

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Influenza
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Mirzakhani, M. Bayat, M. Dashti, M. Tahmasebi, S. Rostamtabar, M. Esmaeili Gouvarchin Ghaleh, H. Amani, J.

The Assessment of Anti-SARS-CoV-2 Antibodies in Different Vaccine Platforms: A Systematic Review and Meta-Analysis of COVID-19 Vaccine Clinical Trial Studies

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Abu Serhan, H. Abu Suilik, H. Hassan, A. K. AlSamhori, J. F. Hassan, A. R. Siddiq, A. Ahmed, N. Elnahry, A. G.

The characteristics of white dot syndromes following COVID-19 Vaccines: a systematic review

  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Untung, T. Pandey, R. Johansson, P.

The cost-effectiveness of COVID-19 vaccination program among age-groups children, adults, and elderly in Europe: A systematic review

  • Europe
  • All age groups
  • COVID-19
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
Loading...